← Back to Patent Explorer
US4530900A Expired / Lapsed US ⏱️ 0.0 years remaining

Soluble insoluble polymers in enzymeimmunoassay

Assignee: Seragen Diagnostics Inc
•
Filing: 1982-09-13
•
Granted: 1985-07-23
•
Expires: 2002-09-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention pertains to an improved heterogeneous enzymeimmunoassay involving the use of a reversibly soluble polymeric substance acting as the support for the antibody. In the direct method the antigen to be detected and an enzyme labeled antigen are bound by antibody which is chemically linked to the soluble polymeric substance. The polymer is rendered insoluble and removed from the test solution. After resolubilization into a solution containing substrate for the enzyme label, the assay for antigen is completed by determination of enzymatic activity. In the indirect method, the antigen to be detected and an enzyme labeled antigen are incubated with a primary antibody unattached to the polymeric substance. After addition of a second antibody which is chemically linked to the polymeric substance, the polymer is rendered insoluble and the assay is performed as in the direct method described above.

Inventors

  • 👤 David L. Marshall

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 04:39
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/536; G01N33/537; G01N33/539; G01N33/543; G01N33/544; G01N33/548; Y; Y10; Y10S; Y10S435/00; Y10S435/969; Y10S435/971; Y10S436/00; Y10S436/815; Y10S436/824; Y10S436/828

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 146 words
A method for determining the presence of a soluble antigen in a test solution which comprises in sequence: (a) allowing a soluble antibody-polymeric substance conjugate to react with the soluble antigen and a soluble antigen-enzyme conjugate in the test solution, said antibody being the reactive complement to said soluble antigen and to the antigen moiety of the antigen-enzyme conjugate thereby to form a reaction product containing said polymeric substance; (b) causing the reaction product containing the polymeric substance to precipitate and separating the solid formed thereby from the test solution; (c) resolubilizing the reaction product containing the polymeric substance to form a second test solution; (d) adding a substrate for the enzyme to said second test solution; and (e) measuring the enzymatic activity in the second test solution compared to the enzymatic activity in a medium derived from a solution having a known amount of antigen.
Claim 2
Independent Claim 146 words
A method for determining the presence of a soluble antigen in a test solution which comprises in sequence: (a) allowing a soluble antibody-polymeric substance conjugate to react with the soluble antigen and a soluble antigen-enzyme conjugate in the test solution, said antibody being the reactive complement to said soluble antigen and to the antigen moiety of the antigen-enzyme conjugate thereby to form a reaction product containing said polymeric substance; (b) causing the reaction product containing the polymeric substance to precipitate and separating the solid formed thereby from the test solution; (c) resolubilizing the reaction product containing the polymeric substance to form a second test solution; (d) adding a substrate for the enzyme to said second test solution; and (e) measuring the enzymatic activity in the second test solution compared to the enzymatic activity in a medium derived from a solution having a known amount of antigen.
Claim 3
Dependent Claim 12 words
A method of claim 1 wherein the polymeric substance is alginic acid.
Claim 4
Dependent Claim 18 words
A method of claim 2 wherein the polymeric substance is rendered insoluble by the addition of calcium ion.
Claim 5
Dependent Claim 10 words
A method of claim 2 wherein the antigen is theophylline.
Claim 6
Independent Claim 214 words
A method for determining the presence of a soluble antigen in a test solution which comprises in sequence: (a) allowing a primary antibody to react with the soluble antigen and a soluble antigen-enzyme conjugate in the test solution, said antibody being the reactive complement to said soluble antigen and to the antigen moiety of the antigen-enzyme conjugate thereby to form a first reaction product containing said primary antibody and said antigen and a second reaction product containing said primary antibody and said antigen-enzyme conjugate; (b) adding a binding agent-polymeric substance conjugate to the resulting solution, said binding agent being capable of binding to said primary antibody and said polymer substance without hindering the ability of the primary antibody to react with the antigen-enzyme conjugate thereby to form a third reaction product containing said polymeric substance; (c) causing the third reaction product containing said polymeric substance to precipitate and separating the solid formed thereby from the test solution; (d) resolubilizing the third reaction product containing said polymeric substance to form a second test solution; (e) adding a substrate for the enzyme to said second test solution; and (f) measuring the enzymatic activity in the second test solution compared to the enzymatic activity in a medium derived from a solution having a known amount of antigen.
Claim 7
Independent Claim 214 words
A method for determining the presence of a soluble antigen in a test solution which comprises in sequence: (a) allowing a primary antibody to react with the soluble antigen and a soluble antigen-enzyme conjugate in the test solution, said antibody being the reactive complement to said soluble antigen and to the antigen moiety of the antigen-enzyme conjugate thereby to form a first reaction product containing said primary antibody and said antigen and a second reaction product containing said primary antibody and said antigen-enzyme conjugate; (b) adding a binding agent-polymeric substance conjugate to the resulting solution, said binding agent being capable of binding to said primary antibody and said polymer substance without hindering the ability of the primary antibody to react with the antigen-enzyme conjugate thereby to form a third reaction product containing said polymeric substance; (c) causing the third reaction product containing said polymeric substance to precipitate and separating the solid formed thereby from the test solution; (d) resolubilizing the third reaction product containing said polymeric substance to form a second test solution; (e) adding a substrate for the enzyme to said second test solution; and (f) measuring the enzymatic activity in the second test solution compared to the enzymatic activity in a medium derived from a solution having a known amount of antigen.
Claim 8
Dependent Claim 16 words
A method of claim 5 wherein the polymeric substance is alginic acid or ethylene-maleic anhydride copolymer.
Claim 9
Dependent Claim 18 words
A method of claim 5 wherein the polymeric substance is rendered insoluble by the addition of calcium ion.
Claim 10
Dependent Claim 14 words
A method of claim 5 wherein the binding agent is avidin or protein A.
Claim 11
Dependent Claim 19 words
A method of claim 5 wherein the binding agent is a second antibody with specificity for the primary antibody.
Claim 12
Dependent Claim 10 words
A method of claim 5 wherein the antigen is theophylline.
Claim 13
Dependent Claim 19 words
A method of claim 8 wherein the binding agent is avidin and the primary antibody is labeled with biotin.

References Cited (Backward Citations)

US4003792A Cited
US3850752A Cited
US3791932A Cited
US4134792A Cited
US4233401A Cited
US4298685A Cited
US4238565A Cited
US4289747A Cited
US4371515A Cited
US4352883A Cited
JPS577557A Cited
US4407957A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-22 1989-01-21 1989-07-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-22 1993-01-21 1993-07-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-22 1997-01-21 1997-07-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag